EJEmily S. Jentes

Emily S. Jentes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emily S. Jentes has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Strengthening State, Tribal, Local, and Territorial Public Health Agencies Through US Centers for Disease Control and Prevention Fellowship Programs

    by Omoshalewa Bamkole, Ahmed M. Kassem, Emily S. Jentes, Jesica R. Jacobs, Jennifer Gordon Wright, Corinne J. Wigington, Wences Arvelo

    Context: Public health fellowship programs play a vital role in strengthening the workforce across state, tribal, local, and territorial (STLT) public health agencies. Program: The US Centers for Disease Control and Prevention’s Epidemic Intelligence Service (EIS) and Laboratory Leadership Service (LLS) fellowships provide structured opportunities for trainees to be placed within STLT public health agencies, where they are intended to contribute directly to essential public health functions. Through these assignments, the objective is for trainees to gain practical experience while STLT public health agencies benefit from additional capacity and public health expertise. Evaluation: Findings from a rapid evaluation showed that EIS and LLS trainees offer crucial support to STLT public health agencies’ delivery of Foundational Public Health Services. The trainees also provide surge support during emergency response events, including infectious disease outbreaks and environmental toxins. Discussion: Public health fellowships are a collaborative model of how federal programs can help alleviate longstanding public health workforce challenges, including difficulties recruiting, hiring, and retaining qualified professionals. Integration of trainees into STLT public health agency operations fosters knowledge transfer, strengthens local capabilities, and supports sustained delivery of public health services. Our findings provide additional evidence that public health fellowship programs can serve as essential support for the national public health workforce.


  • Open Access

    A country classification system to inform rabies prevention guidelines and regulations

    by Ronnie E Henry, Jesse D Blanton, Kristina M Angelo, Emily G Pieracci, Kendra Stauffer, Emily S Jentes, Jessica Allen, Marielle Glynn, Clive M Brown, Cindy R Friedman, et al.

    Background: Assessing the global risk of rabies exposure is a complicated task requiring individual risk assessments, knowledge of rabies epidemiology, surveillance capacity and accessibility of rabies biologics on a national and regional scale. In many parts of the world, availability of this information is limited and when available is often dispersed across multiple sources. This hinders the process of making evidence-based health and policy recommendations to prevent the introduction and spread of rabies. Methods: CDC conducted a country-by-country qualitative assessment of risk and protective factors for rabies to develop an open-access database of core metrics consisting of the presence of lyssaviruses (specifically canine or wildlife rabies virus variants or other bat lyssaviruses), access to rabies immunoglobulins and vaccines, rabies surveillance capacity and canine rabies control capacity. Using these metrics, we developed separate risk scoring systems to inform rabies prevention guidance for travelers and regulations for the importation of dogs. Both scoring systems assigned higher risk to countries with enzootic rabies (particularly canine rabies), and the risk scoring system for travelers also considered protective factors such as the accessibility of rabies biologics for post-exposure prophylaxis. Cumulative scores were calculated across the assessed metrics to assign a risk value of low, moderate or high. Results: A total of 240 countries, territories and dependencies were assessed, for travelers, 116 were identified as moderate to high risk and 124 were low or no risk; for canine rabies virus variant importation, 111 were identified as high-risk and 129 were low or no risk. Conclusions: We developed a comprehensive and easily accessible source of information for assessing the rabies risk for individual countries that included a database of rabies risk and protective factors based on enzootic status and availability of biologics, provided a resource that categorizes risk by country and provided guidance based on these risk categories for travelers and importers of dogs into the United States.


  • Open Access

    Assessment of U.S. Health Care Utilization Patterns Among Recently Resettled Refugees Using Data from the 2016 Annual Survey of Refugees

    by Emma E. Seagle, Curi Kim, Emily S. Jentes

    Purpose: Little is known regarding the health care utilization patterns of refugees resettled in the United States. We analyzed the Annual Survey of Refugees (ASR), a nationally representative survey of recently resettled refugees, to assess these patterns. Methods: Anonymized 2016 ASR data were examined for refugees ≥16 years old who arrived from 2011 to 2014. Results: Refugees most often used private physicians (34%), health clinics (19%), and emergency rooms (14%). Approximately 15% reported no regular source of care, and 34% had health insurance for ≤1 month of the prior year. Conclusion: Results indicate differing health care use and coverage, revealing opportunities for educational interventions.


  • Open Access

    Health screening results of Cubans settling in Texas, USA, 2010–2015: A cross-sectional analysis

    by Emma E. Seagle, Jessica Montour, Deborah Lee, Christina Phares, Emily S. Jentes

    Protecting the health of refugees and other migrant populations in the United States is key to ensuring successful resettlement. Therefore, to identify and address health concerns early, the US Centers for Disease Control and Prevention (CDC) recommends a domestic medical examination (screening for infectious and noninfectious diseases/conditions) shortly after arrival in the US. However, because refugee/migrant populations often have differing health patterns from one another and the US population, the collection and analysis of health information is key to developing population-specific clinical guidelines to guide the care of resettled individuals. Yet little is known regarding the health status of Cubans resettling in the US. Among the tens of thousands of Cuban migrants who have resettled in the US, some applied as refugees in Cuba, some applied for parole (a term used to indicate temporary US admission status for urgent humanitarian reasons or reasons of public benefit under US immigration law) in Cuba, and others applied for parole status after crossing the border. These groups were eligible for US government benefits to help them resettle, including a domestic medical examination. We reviewed health differences found in these examinations of those who were determined to be refugees or parolees in Cuba and those who were given parole status after arrival. We conducted a retrospective cross-sectional analysis of the Texas Department of State Health Services database. Cubans who arrived from 2010 to 2015 and received a domestic medical examination in Texas were included. Those granted refugee/parolee status in Cuba were listed in federal databases for US-bound refugees/parolees; those who were paroled after arrival were not listed. Overall, 2,189 (20%) obtained either refugee or parolee status in Cuba, and 8,709 (80%) received parolee status after arrival. Approximately 62% of those who received parolee status after arrival at the border were male, compared with 49% of those who obtained prior refugee/parolee status in Cuba. Approximately one-half (45%) of those paroled after arrival were 19–34 years old (versus 26% among those who obtained refugee/parolee status in Cuba). Separate models were created for each screening indicator as the outcome, with entry route as the main exposure variable. Crude and adjusted prevalence ratios were estimated using PROC GENMOD procedures in SAS 9.4. Individuals paroled after arrival were less likely to screen positive for parasitic infections (9.6% versus 12.2%; adjusted prevalence ratio: 0.79, 0.71–0.88) and elevated blood lead levels (children ≤16 years old, 5.2% versus 12.3%; adjusted prevalence ratio: 0.42, 0.28–0.63). Limitations include potential disease misclassification, missing clinical information, and cross-sectional nature. Within-country variations in health status are often not examined in refugee populations, yet they are critical to understand granular health trends. Results suggests that the health profiles of Cuban Americans in Texas differed by entry route. This information could assist in developing targeted screenings and health interventions.


  • Open Access

    Clinical Sequelae Associated with Unresolved Tropical Splenomegaly in a Cohort of Recently Resettled Congolese Refugees in the United States-Multiple States, 2015-2018

    by Laura Divens Zambrano, Emily Jentes, Christina Phares, Michelle Weinberg, S. Patrick Kachur, Mukunda Singh Basnet, Alexander Klosovsky, Moses Mwesigwa, Marwan Naoum, Samuel Lubwama Nsobya, et al.

    Tropical splenomegaly is often associated with malaria and schistosomiasis. In 2014 and 2015, 145 Congolese refugees in western Uganda diagnosed with splenomegaly during predeparture medical examinations underwent enhanced screening for various etiologies. After anecdotal reports of unresolved splenomegaly and complications after U.S. arrival, patients were reassessed to describe long-term clinical progression after arrival in the United States. Post-arrival medical information was obtained through medical chart abstraction in collaboration with state health partners in nine participating states. We evaluated observed splenomegaly duration and associated clinical sequelae between 130 case patients from eastern Congo and 102 controls through adjusted hierarchical Poisson models, accounting for familial clustering. Of the 130 case patients, 95 (73.1 %) had detectable splenomegaly after arrival. Of the 85 patients with records beyond 6 months, 45 (52.9%) had persistent splenomegaly, with a median persistence of 14.7 months (range 6.0-27.9 months). Of the 112 patients with available results, 65 (58.0%) patients had evidence of malaria infection, and the mean splenomegaly duration did not differ by Plasmodium species. Refugees with splenomegaly on arrival were 43% more likely to have anemia (adjusted relative risk [aRR]: 1.43, 95% CI: 1.04-1.97). Those with persistent splenomegaly were 60% more likely (adjusted relative risk [aRR]: 1.60, 95% CI: 1.15-2.23) to have a hematologic abnormality, particularly thrombocytopenia (aRR: 5.53, 95% CI: 1.73-17.62), and elevated alkaline phosphatase (aRR: 1.57, 95% CI: 1.03-2.40). Many patients experienced persistent splenomegaly, contradicting literature describing resolution after treatment and removal from an endemic setting. Other possible etiologies should be investigated and effective treatment, beyond treatment for malaria and schistosomiasis, explored.


  • Open Access

    Evaluation of a Program to Improve Linkage to and Retention in Care Among Refugees with Hepatitis B Virus Infection — Three U.S. Cities, 2006–2018

    by Janine Young, Colleen Payton, Patricia Walker, Daniel White, Megan Brandeland, Gayathri S. Kumar, Emily S. Jentes, Ann Settgast, Malini DeSilva

    Identification and management of hepatitis B infection in children and adults from countries with a high prevalence of infection, including refugees, is important for protecting their health and preventing transmission to others.


  • Open Access

    Unresolved Splenomegaly in Recently Resettled Congolese Refugees ― Multiple States, 2015–2018

    by Laura D. Zambrano, Olivia Samson, Christina Phares, Emily Jentes, Michelle Weinberg, Matthew Goers, S. Patrick Kachur, Robert McDonald, Bozena Morawski, Henry Njuguna, et al.

    Despite recommendations, most U.S.-bound Congolese refugees with splenomegaly did not have documented receipt of primaquine after resettlement. Most patients were clustered within families. Approximately 50% of patients with available medical records had persistent splenomegaly >6 months after arrival; 63% of patients with splenomegaly had a hematologic abnormality.


  • Chikungunya and Dengue Virus Infections Among United States Community Service Volunteers Returning from the Dominican Republic, 2014

    by Alexander J. Millman, Douglas H. Esposito, Holly M. Biggs, Michelle Decenteceo, Andrew Klevos, Elizabeth Hunsperger, Jorge Munoz-Jordan, Olga I. Kosoy, Heidi McPherson, Carmen Sullivan, et al.

    Chikungunya spread throughout the Dominican Republic (DR) after the first identified laboratory-confirmed cases were reported in April 2014. In June 2014, a U.S.-based service organization operating in the DR reported chikungunya-like illnesses among several staff. We assessed the incidence of chikungunya virus (CHIKV) and dengue virus (DENV) infection and illnesses and evaluated adherence to mosquito avoidance measures among volunteers/staff deployed in the DR who returned to the United States during July–August 2014. Investigation participants completed a questionnaire that collected information on demographics, medical history, self-reported illnesses, and mosquito exposures and avoidance behaviors and provided serum for CHIKV and DENV diagnostic testing by reverse transcription polymerase chain reaction and IgM enzyme-linked immunosorbent assay. Of 102 participants, 42 (41%) had evidence of recent CHIKV infection and two (2%) had evidence of recent DENV infection. Of the 41 participants with evidence of recent CHIKV infection only, 39 (95%) reported fever, 37 (90%) reported rash, and 37 (90%) reported joint pain during their assignment. All attended the organization's health trainings, and 89 (87%) sought a pretravel health consultation. Most (∼95%) used insect repellent; however, only 30% applied it multiple times daily and < 5% stayed in housing with window/door screens. In sum, CHIKV infections were common among these volunteers during the 2014 chikungunya epidemic in the DR. Despite high levels of preparation, reported adherence to mosquito avoidance measures were inconsistent. Clinicians should discuss chikungunya with travelers visiting areas with ongoing CHIKV outbreaks and should consider chikungunya when diagnosing febrile illnesses in travelers returning from affected areas.


  • Open Access

    Pre-Travel Medical Preparation of Business and Occupational Travelers

    by Nomana M. Khan, Emily S. Jentes, Clive Mbbs Brown, Pauline Ma Han, Sowmya R. Rao, Phyllis Kozarsky, Stefan H.F. Hagmann, Regina C. LaRocque, Edward T. Ryan

    Objectives: The aim of the study was to understand more about pre-travel preparations and itineraries of business and occupational travelers. Methods: De-identified data from 18 Global TravEpiNet clinics from January 2009 to December 2012 were analyzed. Results: Of 23,534 travelers, 61% were non-occupational and 39% occupational. Business travelers were more likely to be men, had short times to departure and shorter trip durations, and commonly refused influenza, meningococcal, and hepatitis B vaccines. Most business travelers indicated that employers suggested the pre-travel health consultation, whereas non-occupational travelers sought consultations because of travel health concerns. Conclusions: Sub-groups of occupational travelers have characteristic profiles, with business travelers being particularly distinct. Employers play a role in encouraging business travelers to seek pre-travel consultations. Such consultations, even if scheduled immediately before travel, can identify vaccination gaps and increase coverage.


  • Open Access

    Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet

    by Bhushan R. Deshpande, Sowmya R. Rao, Emily S. Jentes, Susan L. Hills, Marc Fischer, Mark D. Gershman, Gary W. Brunette, Edward T. Ryan, Regina C. LaRocque

    Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.